Skip to main content

With genetics research marching forward, keeping up with all the new discoveries in the field can be a challenge for geneticists—and investors are betting startup Emedgene has a solution.

Emedgene has raised $6 million to expand sales of an artificial intelligence-based software platform that automates genetic interpretation. Geneticists use this decision-support system to help ensure they don’t miss important pieces of evidence in a genetic test that could help them diagnose a patient, according to co-founder and Chief Executive Einat Metzer.